COMMUNIQUÉS West-GlobeNewswire

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 33 - 2026
17/08/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 11 août 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 33 - 2026
17/08/2026
Aggregated presentation by day and by market Weekly report on share repurchases on 11th August 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily [...]
MD Logic Health Unveils Innovative Daily Multi-Fiber Supplement Featuring Clinically-Proven Solnul Resistant Potato Starch
17/08/2026
Powered by a robust 4-fiber formulation of both soluble and insoluble fibers to promote natural satiety, metabolic balance, and comfortable regularity. Miami, FLORIDA, Aug. 17, 2026 (GLOBE NEWSWIRE) -- MD Logic Health [...]
Cooper Clinic Introduces Digital Nutrition Platform
17/08/2026
Online nutrition community classes launch September 29 DALLAS , Aug. 17, 2026 (GLOBE NEWSWIRE) -- Cooper Clinic announces the addition of The Learning Plate digital platform to its nutrition services offerings. This [...]
Pharmacy Planet surpasses 200,000 YouTube subscribers and highlights the growth of its healthcare education platform
17/08/2026
How one UK pharmacy is redefining health education by turning expert conversations into content that hundreds of thousands of people actively choose to watch LONDON, Aug. 17, 2026 (GLOBE NEWSWIRE) -- In an age where [...]
NTHI’s Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results
17/08/2026
DENVER, Aug. 17, 2026 (GLOBE NEWSWIRE) -- There is a tendency to think of a Nasdaq listing as simply a better place for a stock to trade. For NeOnc Technologies Holdings (NASDAQ: NTHI), however, the Nasdaq Global Market [...]
Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies
17/08/2026
The Patent Claims are for the Intended Commercial Formulation of ART27.13 Expected to Extend Patent Protection for ART27.13 through 2041 SOLANA BEACH, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. ( [...]
Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment
17/08/2026
Pluri's majority-owned food-tech company adds aquatic cell biology, animal-component-free media capabilities and a European scientific presence Ever After Foods secures an additional $2 million strategic investment [...]
Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/08/2026
NORWOOD, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage company focused on new therapies in oncology and obesity, today announced the grant of inducement [...]
Bridging Healthcare and Football: How Ballipinar Dental Clinic is Scoring Big in the UK Market
17/08/2026
CEO of Antalya-based dental healthcare provider Ballipinar Dental Clinic Rıdvan Ballipinar talks about how they created international visibility and connections through their partnership with English football club [...]
DentSpa Earns GHA Certification for Its International Patient Experience
17/08/2026
Global Healthcare Accreditation (GHA) recognizes DentSpa’s systems to support patients before their trip, during their treatment in Istanbul and after their return Photo: DentSpa executives with GHA team ISTANBUL, Aug. [...]
Zealand Pharma - Transactions related to share buy-back program (week 33, 2026)
17/08/2026
Company announcement No. 40 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 33, 2026) Copenhagen, Denmark, August 17, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
Coloplast A/S - Announcement no. 6/2026 - Coloplast announces changes to Executive Leadership Team
17/08/2026
Coloplast announces changes to Executive Leadership Team Today, Coloplast announces two changes to the company’s Executive Leadership Team (ELT). The changes strengthen the leadership of Coloplast’s people & culture [...]
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
17/08/2026
BOTHELL, Wash., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) ("Cocrystal" or the "Company"), a clinical-stage biotechnology company developing novel therapeutics to meet the growing global [...]
GHK-Cu Peptide Launched By Kylo Peptides for Laboratory Research Applications
17/08/2026
Sheridan,Wyoming, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides [ https://kylopeptides.com ] has added GHK-Cu peptide to its catalog of laboratory research materials, expanding the range of copper-binding compounds [...]
InspireMD Reports Second Quarter 2026 Financial Results
17/08/2026
- Company to host investor conference call today, August 17 th , at 8:30am EDT - MIAMI, Aug. 17, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard ® Prime [...]
Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer
17/08/2026
The New Mechanistic Findings Support Can-Fite’s Ongoing Phase IIb Study Design Following Positive Phase IIa Results Ramat Gan, Israel, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd . (NYSE American: CANF) ( [...]
EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD
17/08/2026
– DURAVYU was non-inferior to on-label aflibercept control (nominal p-value = 0.0096) in an ad hoc analysis excluding a 4% asymmetric cohort (9 of 211 patients) who experienced vision loss (≥ 15 letters) unrelated to [...]
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET
17/08/2026
Key recent and second quarter highlights include: Completed first-cycle FDA review of the Company’s ANDA for preservative-free ketamine with no drug-related major deficiencies. The sole remaining item, a manufacturer's [...]

Pages